Response To Interferon Therapy
Study of PKRBD in HCV genotype 3a infected patients in response to interferon therapy in Pakistani population
8
Interleukin 27 polymorphisms in HCV RNA positive patients: is there an impact on response to interferon therapy?
6
STUDY THE EXPRESSION OF TETRASPANIN (CD81) ON B CELLS IN RESPONSE TO INTERFERON THERAPY IN CHRONIC HCV PATIENTS
6
Type I interferon receptor in peripheral blood mononuclear cells may predict response to intra-arterial 5-fluorouracil + interferon therapy for advanced hepatocellular carcinoma
8
HCV NS5A region and response to pegylated interferon alpha plus ribavirin therapy: mutational analyses in patients with chronic HCV infection
10
A mutation in the interferon regulatory element of HBV may influence the response of interferon treatment in chronic hepatitis B patients
6
Monitoring the Treatment of Hepatitis C Viral Infection by Molecular Techniques
10
Effect of adjuvant interferon therapy on hepatitis B virus related hepatocellular carcinoma: a systematic review
8
Identifying responders and nonresponders to interferon therapy in multiple sclerosis
10
AMINO ACID SEQUENCE VARIATIONS WITHIN ENVELOPED PROTEIN 2 (E2) OF HEPATITIS C VIRUS SUBTYPE 3a AND RESPONSE TO INTERFERON ALPHA PLUS RIBAVIRIN COMBINATION THERAPY
12
The Antiviral Response to Gamma Interferon
9
Prediction of response to pegylated interferon α and ribavirin therapy in Chinese patients infected with different hepatitis C virus genotype
6
Sustained Biochemical and Virological Response of Different HCV Genotypes to Interferon-Alpha Plus Ribavirin Combination Therapy
9
Induction of Host Gene Expression following Infection of Chicken Embryo Fibroblasts with Oncogenic Marek's Disease Virus
7
Interaction of interferon alpha therapy with thyroid function tests in the management of hepatitis C: a case report
5
Natural killer cell in systemic lupus erythematosus Defects in effector lytic activity and response to interferon and interferon inducers
11
Incidence rates of tuberculosis in chronic hepatitis C infected patients with or without interferon based therapy: a population based cohort study in Taiwan
8
Interferon alpha therapy for hepatitis C: treatment completion and response rates among patients with substance use disorders
8
Benefit of Hepatitis C Virus Core Antigen Assay in Prediction of Therapeutic Response to Interferon and Ribavirin Combination Therapy
6
Cell-Specific Regulation of Nucleic Acid Sensor Cascades: a Controlling Interest in the Antiviral Response
10